Celldex Therapeutics Correlations

CLDX Stock

USD 26.76 1.38 4.90%

The current 90-days correlation between Celldex Therapeutics and Ideaya Biosciences is 0.23 (i.e., Modest diversification). The correlation of Celldex Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Celldex Therapeutics Correlation With Market

Weak diversification

The correlation between Celldex Therapeutics and DJI is 0.32 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Celldex Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Celldex Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

For more information on how to buy Celldex Stock please use our How to Invest in Celldex Therapeutics guide.

Moving together with Celldex Stock

0.94	FDMT	4D Molecular Therapeutics	Pair Corr
0.77	JNJ	Johnson Johnson Sell-off Trend	Pair Corr
0.9	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.65	INKT	Mink Therapeutics	Pair Corr
0.93	NKTX	Nkarta Inc	Pair Corr
0.67	PEPG	PepGen	Pair Corr
0.8	RGNX	Regenxbio	Pair Corr
0.87	ADAP	Adaptimmune Therapeutics	Pair Corr
0.64	AFMD	Affimed NV	Pair Corr
0.74	STOK	Stoke Therapeutics Sell-off Trend	Pair Corr
0.92	BDTX	Black Diamond Therap	Pair Corr

Moving against Celldex Stock

0.85	BMY	Bristol Myers Squibb Sell-off Trend	Pair Corr
0.75	NAMS	NewAmsterdam Pharma	Pair Corr
0.55	PMVP	Pmv Pharmaceuticals	Pair Corr
0.52	ESLAW	Estrella Immunopharma	Pair Corr
0.51	PHVS	Pharvaris BV	Pair Corr
0.5	OPT	Opthea	Pair Corr
0.42	PLRX	Pliant Therapeutics	Pair Corr
0.86	CRVS	Corvus Pharmaceuticals	Pair Corr
0.81	AVTE	Aerovate Therapeutics	Pair Corr
0.7	ABEO	Abeona Therapeutics	Pair Corr
0.7	SGMO	Sangamo Therapeutics Buyout Trend	Pair Corr
0.64	VREX	Varex Imaging Corp	Pair Corr
0.4	AGIO	Agios Pharm	Pair Corr

Related Correlations Analysis

	IDYA	ANAB	MGTX	KROS	FIXX	CERE	RNA	RVMD	DAWN	SWTX
IDYA		0.71	-0.63	-0.58	0.0	0.24	-0.34	-0.72	-0.01	0.55	IDYA
ANAB	0.71		-0.78	-0.42	0.51	0.1	-0.16	-0.9	-0.21	0.13	ANAB
MGTX	-0.63	-0.78		0.59	-0.34	-0.18	0.44	0.87	0.48	-0.28	MGTX
KROS	-0.58	-0.42	0.59		-0.24	-0.04	0.6	0.6	0.61	-0.71	KROS
FIXX	0.0	0.51	-0.34	-0.24		-0.22	0.11	-0.37	-0.38	-0.02	FIXX
CERE	0.24	0.1	-0.18	-0.04	-0.22		-0.03	-0.21	0.17	-0.17	CERE
RNA	-0.34	-0.16	0.44	0.6	0.11	-0.03		0.41	0.46	-0.48	RNA
RVMD	-0.72	-0.9	0.87	0.6	-0.37	-0.21	0.41		0.36	-0.21	RVMD
DAWN	-0.01	-0.21	0.48	0.61	-0.38	0.17	0.46	0.36		-0.37	DAWN
SWTX	0.55	0.13	-0.28	-0.71	-0.02	-0.17	-0.48	-0.21	-0.37		SWTX
	IDYA	ANAB	MGTX	KROS	FIXX	CERE	RNA	RVMD	DAWN	SWTX

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

RVMD	+ 0.87	MGTX
ANAB	+ 0.71	IDYA
DAWN	+ 0.61	KROS
RNA	+ 0.6	KROS
RVMD	+ 0.6	KROS
KROS	+ 0.59	MGTX

High negative correlations

RVMD	- 0.9	ANAB
MGTX	- 0.78	ANAB
RVMD	- 0.72	IDYA
SWTX	- 0.71	KROS
MGTX	- 0.63	IDYA
KROS	- 0.58	IDYA

Risk-Adjusted Indicators

There is a big difference between Celldex Stock performing well and Celldex Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Celldex Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
IDYA	2.21	(0.76)	0.00	(0.36)	0.00	0.00	4.15	(5.09)	15.21
ANAB	3.47	(0.84)	0.00	(0.14)	0.00	0.00	5.77	(7.28)	35.57
MGTX	2.67	0.50	0.20	0.38	2.49	(3.05)	6.75	(5.68)	21.07
KROS	2.07	0.21	0.11	0.27	2.16	(2.26)	4.39	(4.31)	16.94
FIXX	2.82	0.17	0.01	(0.59)	3.52	(3.25)	5.77	(5.61)	19.43
CERE	0.77	0.03	(0.04)	0.21	0.94	(1.02)	1.91	(1.59)	6.40
RNA	2.92	(0.15)	(0.01)	0.04	4.23	(2.99)	5.78	(7.08)	27.94
RVMD	2.02	0.32	0.14	0.40	2.03	(2.17)	4.81	(3.24)	10.95
DAWN	2.07	(0.17)	0.00	(0.09)	0.00	0.00	3.84	(3.69)	11.44
SWTX	2.18	(0.13)	0.00	(0.03)	0.00	0.00	4.86	(4.36)	12.80

Celldex Therapeutics Corporate Management

Ronald Pepin	Chief Bus. Officer and Sr. VP	Profile
Patrick Till	Senior Communications	Profile
Prof Schlessinger	CoFounder Board	Profile
Diane MD	Senior Officer	Profile
Margo MD	Senior Affairs	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC